(Q73081846)
Statements
Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis (English)
Y Dong
M D Walsh
M A McGuckin
B G Gabrielli
M C Cummings
R G Wright
T Hurst
1 February 1997